These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 25991051)

  • 1. Genetic variability in GLP-1 receptor is associated with inter-individual differences in weight lowering potential of liraglutide in obese women with PCOS: a pilot study.
    Jensterle M; Pirš B; Goričar K; Dolžan V; Janež A
    Eur J Clin Pharmacol; 2015 Jul; 71(7):817-24. PubMed ID: 25991051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in the Treatment of Obese Women with Polycystic Ovary Syndrome.
    Tzotzas T; Karras SN; Katsiki N
    Curr Vasc Pharmacol; 2017; 15(3):218-229. PubMed ID: 28003008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity, Polycystic Ovary Syndrome, and Infertility: A New Avenue for GLP-1 Receptor Agonists.
    Cena H; Chiovato L; Nappi RE
    J Clin Endocrinol Metab; 2020 Aug; 105(8):e2695-709. PubMed ID: 32442310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome.
    Jensterle M; Kravos NA; Pfeifer M; Kocjan T; Janez A
    Hormones (Athens); 2015; 14(1):81-90. PubMed ID: 25885106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucagon-Like Peptide 1 (GLP-1) Receptor Variants and Glycemic Response to Liraglutide: A Pharmacogenetics Study in Iranian People with Type 2 Diabetes Mellitus.
    Eghbali M; Alaei-Shahmiri F; Hashemi-Madani N; Emami Z; Mostafavi L; Malek M; Khamseh ME
    Adv Ther; 2024 Feb; 41(2):826-836. PubMed ID: 38172377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allelic variant in the glucagon-like peptide 1 receptor gene associated with greater effect of liraglutide and exenatide on gastric emptying: A pilot pharmacogenetics study.
    Chedid V; Vijayvargiya P; Carlson P; Van Malderen K; Acosta A; Zinsmeister A; Camilleri M
    Neurogastroenterol Motil; 2018 Jul; 30(7):e13313. PubMed ID: 29488276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short term monotherapy with GLP-1 receptor agonist liraglutide or PDE 4 inhibitor roflumilast is superior to metformin in weight loss in obese PCOS women: a pilot randomized study.
    Jensterle M; Salamun V; Kocjan T; Vrtacnik Bokal E; Janez A
    J Ovarian Res; 2015 Jun; 8():32. PubMed ID: 26032655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of glucagon-like peptide-1 in reproduction: from physiology to therapeutic perspective.
    Jensterle M; Janez A; Fliers E; DeVries JH; Vrtacnik-Bokal E; Siegelaar SE
    Hum Reprod Update; 2019 Jul; 25(4):504-517. PubMed ID: 31260047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of liraglutide on ectopic fat in polycystic ovary syndrome: A randomized clinical trial.
    Frøssing S; Nylander M; Chabanova E; Frystyk J; Holst JJ; Kistorp C; Skouby SO; Faber J
    Diabetes Obes Metab; 2018 Jan; 20(1):215-218. PubMed ID: 28681988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term intervention with liraglutide improved eating behavior in obese women with polycystic ovary syndrome.
    Jensterle M; Kocjan T; Kravos NA; Pfeifer M; Janez A
    Endocr Res; 2015; 40(3):133-8. PubMed ID: 25330463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of weight loss and metabolic changes in diabetic patients treated with liraglutide, effect of RS 6923761 gene variant of glucagon-like peptide 1 receptor.
    de Luis DA; Diaz Soto G; Izaola O; Romero E
    J Diabetes Complications; 2015; 29(4):595-8. PubMed ID: 25825013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exposure-response analyses of liraglutide 3.0 mg for weight management.
    Wilding JP; Overgaard RV; Jacobsen LV; Jensen CB; le Roux CW
    Diabetes Obes Metab; 2016 May; 18(5):491-9. PubMed ID: 26833744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Prevented Weight Regain in Obese Women with Polycystic Ovary Syndrome Previously Treated with Liraglutide: A Pilot Randomized Study.
    Ferjan S; Janez A; Jensterle M
    Metab Syndr Relat Disord; 2017 Dec; 15(10):515-520. PubMed ID: 29064743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term combined treatment with liraglutide and metformin leads to significant weight loss in obese women with polycystic ovary syndrome and previous poor response to metformin.
    Jensterle Sever M; Kocjan T; Pfeifer M; Kravos NA; Janez A
    Eur J Endocrinol; 2014 Mar; 170(3):451-9. PubMed ID: 24362411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GLP-1 Receptor Agonist Treatment Increases Bone Formation and Prevents Bone Loss in Weight-Reduced Obese Women.
    Iepsen EW; Lundgren JR; Hartmann B; Pedersen O; Hansen T; Jørgensen NR; Jensen JE; Holst JJ; Madsbad S; Torekov SS
    J Clin Endocrinol Metab; 2015 Aug; 100(8):2909-17. PubMed ID: 26043228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liraglutide and polycystic ovary syndrome: is it only a matter of body weight?
    Pugliese G; de Alteriis G; Muscogiuri G; Barrea L; Verde L; Zumbolo F; Colao A; Savastano S
    J Endocrinol Invest; 2023 Sep; 46(9):1761-1774. PubMed ID: 37093453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on the effects of GLP-1 receptor agonists for the treatment of polycystic ovary syndrome.
    Siamashvili M; Davis SN
    Expert Rev Clin Pharmacol; 2021 Sep; 14(9):1081-1089. PubMed ID: 34015974
    [No Abstract]   [Full Text] [Related]  

  • 18. The effects of treatment with liraglutide on quality of life and depression in young obese women with PCOS and controls.
    Kahal H; Kilpatrick E; Rigby A; Coady A; Atkin S
    Gynecol Endocrinol; 2019 Feb; 35(2):142-145. PubMed ID: 30599799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term effectiveness of low dose liraglutide in combination with metformin versus high dose liraglutide alone in treatment of obese PCOS: randomized trial.
    Jensterle M; Kravos NA; Goričar K; Janez A
    BMC Endocr Disord; 2017 Jan; 17(1):5. PubMed ID: 28143456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liraglutide increases IVF pregnancy rates in obese PCOS women with poor response to first-line reproductive treatments: a pilot randomized study.
    Salamun V; Jensterle M; Janez A; Vrtacnik Bokal E
    Eur J Endocrinol; 2018 Jul; 179(1):1-11. PubMed ID: 29703793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.